VATOR SPLASH HEALTH CONFERENCE


How are innovators disrupting healthcare?







Post2 1 8de40f05e09e4633ed293f754fb8b2258094be8d2365de700682bbe84fdb596f

Vator Splash Health Conference:

How are innovators disrupting healthcare?


Javier avatar 7a142510f329990068a573ba676ca69b58e2268ba6fec2a346c8265984dff76dJavier Noris wrote this on Feb 19, 2016



Want to meet the ScienceVest team? Then come join us at the Vator Splash Health Conference taking place Tuesday February 23rd at the Kaiser Center in Oakland.

The event is a who is who of the health entrepreneurship community. Top VC's and innovators in the space are on the agenda as speakers. After the event we will head on over with the attendees to Lake Chalet for happy hour. For more information head over to the vator event page here . We hope you can join us and register here to attend.








Sciencevest © 2016

This site is operated by ScienceVest Inc.,"ScienceVest", which is not a registered broker-dealer. ScienceVest does not give investment advice, endorsement, analysis or recommendations with respect to any securities. All securities listed here are being offered by, and all information included on this site is the responsibility of, the applicable issuer of such securities. ScienceVest has not taken any steps to verify the adequacy, accuracy, or completeness of any information. Neither ScienceVest nor any of its officers, directors, agents and employees makes any warranty, express or implied, of any kind whatsoever related to the adequacy, accuracy or completeness of any information on this site of the use of information on this site.

This website is intended solely for accredited investors. Investments in private placements and startup investments in particular are speculative and involve a high degree of risk and those investors who cannot afford to lose their entire investment should not invest in start-ups. Companies seeking startup investments tend to be in earlier stages of development and their business model, products and services may not yet be fully developed, operational or tested in the public marketplace. There is no guarantee that the stated valuation and other terms are accurate or in agreement with the market or industry valuations. Additionally, investors may receive restricted stock that may be subject to holding period requirements. Investments in early-stage private companies should only be part of your overall investment portfolio. Furthermore, the allocation to this asset sub-class may be best fulfilled through a balanced portfolio of different start-ups. Investments in startups are highly illiquid and those investors who cannot hold an investment for the long term (at least 5-7 years) should not invest.